HEADER TRANSCRIPTION 01-MAY-06 2GUT TITLE SOLUTION STRUCTURE OF THE TRANS-ACTIVATION DOMAIN OF THE HUMAN CO- TITLE 2 ACTIVATOR ARC105 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ARC/MEDIATOR, POSITIVE COFACTOR 2 GLUTAMINE/Q-RICH- COMPND 3 ASSOCIATED PROTEIN; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: ARC/MEDIATOR KIX DOMAIN, RESIDUES 5-78; COMPND 6 SYNONYM: PC2 GLUTAMINE/Q-RICH-ASSOCIATED PROTEIN, TPA-INDUCIBLE GENE COMPND 7 1 PROTEIN, TIG-1, ACTIVATOR-RECRUITED COFACTOR 105 KDA COMPONENT, COMPND 8 ARC105, CTG REPEAT PROTEIN 7A; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PCQAP, ARC105, CTG7A, TIG1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24 KEYWDS KIX, 3 HELICAL BUNDLE, TRANSCRIPTION EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR B.W.VOUGHT,Z.-Y.JIM SUN,S.G.HYBERTS,G.WAGNER,A.M.NAAR REVDAT 4 09-MAR-22 2GUT 1 REMARK SEQADV REVDAT 3 24-FEB-09 2GUT 1 VERSN REVDAT 2 22-AUG-06 2GUT 1 JRNL REVDAT 1 08-AUG-06 2GUT 0 JRNL AUTH F.YANG,B.W.VOUGHT,J.S.SATTERLEE,A.K.WALKER,Z.-Y.JIM SUN, JRNL AUTH 2 J.L.WATTS,R.DEBEAUMONT,R.MAKO SAITO,S.G.HYBERTS,S.YANG, JRNL AUTH 3 C.MACOL,L.IYER,R.TJIAN,S.VAN DEN HEUVEL,A.C.HART,G.WAGNER, JRNL AUTH 4 A.M.NAAR JRNL TITL AN ARC/MEDIATOR SUBUNIT REQUIRED FOR SREBP CONTROL OF JRNL TITL 2 CHOLESTEROL AND LIPID HOMEOSTASIS. JRNL REF NATURE V. 442 700 2006 JRNL REFN ISSN 0028-0836 JRNL PMID 16799563 JRNL DOI 10.1038/NATURE04942 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROSA 3.7, CYANA 2.1 REMARK 3 AUTHORS : GUNTERT (PROSA), GUNTERT (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GUT COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1000037575. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : 30 MM NACL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM ARC105 U-15N, 13C, 30MM REMARK 210 NACL, 10MM PHOSPHATE BUFFER, 90% REMARK 210 H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : HNCA; HNCOCA; HNCACB; HNCOCACB; REMARK 210 HNCACO; HN(COCA)NH; N15NOESY; REMARK 210 TOCSY; CCONH; HCCONH; ALIPHATIC; REMARK 210 AROMATIC-C13NOESY; HCCHTOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ; 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CARA 1.5, CYANA 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING USING CYANA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST NOE TARGET FUNCTION WITH REMARK 210 NO NOE VIOLATIONS > 0.5 A, AND REMARK 210 ANGULAR VIOLATIONS > 5 DEG REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 3 -48.71 -162.51 REMARK 500 1 GLN A 6 -175.79 -64.37 REMARK 500 1 GLU A 7 27.31 -160.70 REMARK 500 1 ASP A 9 61.75 -151.16 REMARK 500 1 ALA A 33 120.40 -178.36 REMARK 500 1 HIS A 34 -64.71 -178.60 REMARK 500 1 SER A 35 -175.81 -60.32 REMARK 500 1 LYS A 72 178.50 63.16 REMARK 500 1 GLN A 75 -73.98 -72.25 REMARK 500 1 ALA A 76 99.52 60.50 REMARK 500 2 GLN A 6 94.65 60.55 REMARK 500 2 HIS A 34 75.36 62.85 REMARK 500 2 SER A 37 159.35 178.63 REMARK 500 2 LYS A 72 -170.47 -61.78 REMARK 500 2 LYS A 73 102.59 -53.05 REMARK 500 2 SER A 74 138.63 -179.14 REMARK 500 2 ALA A 76 -75.45 -166.35 REMARK 500 2 SER A 77 -70.08 -170.53 REMARK 500 3 ALA A 33 91.43 -178.46 REMARK 500 3 HIS A 34 70.23 -169.95 REMARK 500 3 SER A 35 -74.46 -177.71 REMARK 500 3 LYS A 36 -69.04 -175.17 REMARK 500 3 LYS A 72 82.35 62.83 REMARK 500 3 SER A 77 102.21 -56.39 REMARK 500 4 GLU A 7 29.80 -145.48 REMARK 500 4 HIS A 34 74.84 58.76 REMARK 500 4 SER A 37 160.00 178.75 REMARK 500 4 LYS A 72 -169.81 -61.55 REMARK 500 4 SER A 74 -74.35 -178.31 REMARK 500 4 ALA A 76 -169.90 -173.15 REMARK 500 5 MET A 4 101.08 63.17 REMARK 500 5 VAL A 32 -43.81 -130.30 REMARK 500 5 HIS A 34 46.05 -146.37 REMARK 500 5 SER A 35 18.94 -150.25 REMARK 500 5 LYS A 36 -70.55 71.71 REMARK 500 5 SER A 37 156.11 178.90 REMARK 500 5 SER A 74 71.95 57.63 REMARK 500 6 ALA A 3 -171.13 54.03 REMARK 500 6 GLN A 6 175.21 62.75 REMARK 500 6 THR A 8 168.85 61.39 REMARK 500 6 VAL A 32 -74.98 -124.55 REMARK 500 6 ALA A 33 94.60 62.11 REMARK 500 6 HIS A 34 -66.13 -165.42 REMARK 500 6 SER A 35 173.04 -54.00 REMARK 500 6 LYS A 73 103.55 -52.01 REMARK 500 6 SER A 74 40.05 -159.06 REMARK 500 7 GLU A 7 -174.32 -178.17 REMARK 500 7 ALA A 33 54.15 -170.74 REMARK 500 7 HIS A 34 -73.79 -119.95 REMARK 500 7 SER A 35 176.39 -55.90 REMARK 500 REMARK 500 THIS ENTRY HAS 113 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2GUT A 5 78 UNP Q96RN5 PCQAP_HUMAN 5 78 SEQADV 2GUT GLY A 2 UNP Q96RN5 CLONING ARTIFACT SEQADV 2GUT ALA A 3 UNP Q96RN5 CLONING ARTIFACT SEQADV 2GUT MET A 4 UNP Q96RN5 CLONING ARTIFACT SEQRES 1 A 77 GLY ALA MET GLY GLN GLU THR ASP TRP ARG SER THR ALA SEQRES 2 A 77 PHE ARG GLN LYS LEU VAL SER GLN ILE GLU ASP ALA MET SEQRES 3 A 77 ARG LYS ALA GLY VAL ALA HIS SER LYS SER SER LYS ASP SEQRES 4 A 77 MET GLU SER HIS VAL PHE LEU LYS ALA LYS THR ARG ASP SEQRES 5 A 77 GLU TYR LEU SER LEU VAL ALA ARG LEU ILE ILE HIS PHE SEQRES 6 A 77 ARG ASP ILE HIS ASN LYS LYS SER GLN ALA SER VAL HELIX 1 1 SER A 12 GLY A 31 1 20 HELIX 2 2 SER A 37 ALA A 49 1 13 HELIX 3 3 THR A 51 LYS A 72 1 22 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1